The t(12;21) is a recurring chromosomal abnormality in acute lymphobla
stic leukaemias (ALLs) which results in the production of an ETV6-AML1
fusion gene. The association between t(12;21) and the deletion of the
untranslocated allele of ETV6 is among the most frequent abnormalitie
s observed in B-lineage ALLs in children. In order to study the protei
ns encoded by ETV6 and ETV6-AML1, we raised polyclonal antibodies dire
cted against a recombinant peptide corresponding to the junctional reg
ion of ETV6-AML1. Cell lysates from various leukaemic cell lines, and
from children with B- and T-lineage ALLs, wee studied by Western blot.
Two isoforms of ETV6 protein were detected in normal bone marrow cell
s and in leukaemic cells without 12p alteration: a major form (apparen
t m.w. 63 kD) and a minor one (apparent m.w. 53 kD). In the REH cell l
ine, which expresses the ETV6-AML1 fusion transcript and no normal ETV
6 mRNA, the ETV6 isoforms were absent and two new bands were detected
corresponding to ETV6-AML1 protein products (apparent m.w. 95 and 105
kD). A similar pattern was obtained with blast cells from patients wit
h a t(12;21) and a deletion of ETV6. In two patients with a t(12;21) b
ut no deletion of ETV6, four bands were detected corresponding to both
the normal ETV6 and ETV6-AML1 proteins, suggesting that in these case
s the second ETV6 allele was not inactivated. Surprisingly, the expres
sion pattern of ETV6 differed widely from patient to patient. In three
out of 13 patients without t(12;21), the relative intensity of the ba
nds corresponding to ETV6 isoforms in blast cells from patients was co
mpletely different from normal cells, with a marked predominance of th
e 53 kD isoform. The pattern of ETV6 expression was normal in bone mar
row from the same patients during remission. These finding suggest tha
t ETV6 abnormalities are not restricted to patients with translocation
s or deletions involving this gene.